GlassScriptPhysician profile
Philip H Johnson
NPI 1245222959
$2,309.98
in general payments reported to CMS, 2019-2025
26 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $147 · 2021: $207 · 2022: $201 · 2023: $156 · 2024: $648 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $451.49 | 2021-2025 | Mako, Blueprint Patient Specific Instrumentation, T2 Alpha |
| Djo, LLC | $440.77 | 2020-2025 | Cmf |
| Horizon Therapeutics Plc | $240.66 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $210.22 | 2019 | |
| Radius Health, INC. | $182.64 | 2023-2025 | Tymlos |
| Heron Therapeutics, INC. | $128.71 | 2022-2025 | Zynrelef |
| Medical Device Business Services, INC. | $88.55 | 2024 | Motoband |
| Vertex Pharmaceuticals Incorporated | $78.78 | 2024-2025 | |
| Pacira Therapeutics, INC. | $65.99 | 2019 | |
| Polynovo North America LLC | $47.27 | 2022-2024 | Novosorb Btm |
| Misonix INC | $41.94 | 2019 | |
| Baudax Bio INC. | $39.66 | 2020 | |
| Bioventus LLC | $38.10 | 2024 | Durolane |
| Astellas Pharma US INC | $25.06 | 2024 | Veozah |
| Innovation Technologies INC | $23.93 | 2024 | Irrisept |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $23.08 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Amgen INC. | $23.04 | 2024 | |
| Ethicon US, LLC | $22.47 | 2022 | |
| Kerecis Limited | $20.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $19.35 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Axogen | $19.03 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.43 | 2019 | |
| Heraeus Medical, LLC. | $16.84 | 2021 | |
| Sanara Medtech INC. | $15.58 | 2024 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $15.05 | 2025 | Exparel |
| Shire North American Group INC | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.